Are differential co-payment rates appropriate in the health sector ?
In this paper we discuss the interest of applying differential co-payment rates across alternative medical treatments. Two treatment strategies are considered: a "long term strategy" in which patients apply preventive measures before knowing if they have the desease and an "emergency strategy" where patients are treated on contraction of the disease. We show that the second approach should be more generously subsidized by the regulator.
|Date of creation:||00 Oct 2004|
|Contact details of provider:|| Postal: Voie du Roman Pays 34, 1348 Louvain-la-Neuve (Belgium)|
Fax: +32 10474304
Web page: http://www.uclouvain.be/core
More information through EDIRC
Please report citation or reference errors to , or , if you are the registered author of the cited work, log in to your RePEc Author Service profile, click on "citations" and make appropriate adjustments.:
- Byrne, Margaret M. & Thompson, Peter, 2001. "Screening and preventable illness," Journal of Health Economics, Elsevier, vol. 20(6), pages 1077-1088, November.
- Breyer, Friedrich, 1982. "Rational purchase of medical care and differential insurance coverage for diagnostic services," Journal of Health Economics, Elsevier, vol. 1(2), pages 147-156, August.
When requesting a correction, please mention this item's handle: RePEc:cor:louvco:2004070. See general information about how to correct material in RePEc.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: (Alain GILLIS)
If references are entirely missing, you can add them using this form.